Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111824 · ClinicalTrials.gov registry record · Phase 1
A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy
A Phase 1 study, sponsored by The Methodist Hospital Research Institute.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT02111824 is a Phase 1 study that was terminated before completion, run by The Methodist Hospital Research Institute. The registered enrollment target is 7 participants.
The verdict
NCT02111824, a Phase 1 study, was terminated before completion, sponsored by The Methodist Hospital Research Institute.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to test the use of a minimally invasive multimodality image-guided (MIMIG) intervention system used for performing a lung biopsy. The safety of the MIMIG intervention system will also be studied.
Interventions
- DRUG Indocyanine Green (ICG)
- DEVICE MIMIG System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-01-05 |
| Est. Completion | 2019-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02111824
The ClinicalTrials.gov registry entry for NCT02111824 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine Green (ICG) is the first listed.
NCT02111824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02111824 about?
NCT02111824 is a clinical study titled "A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy". The goal of this clinical research study is to test the use of a minimally invasive multimodality image-guided (MIMIG) intervention system used for performing a lung biopsy. The safety of the MIMIG intervention system will also be studied.
What is the current status of trial NCT02111824?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2014-01-05. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02111824?
The interventions under investigation include: Indocyanine Green (ICG) (DRUG), MIMIG System (DEVICE).
Who is sponsoring clinical trial NCT02111824?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.